Clinical algorithms increasingly influence medication surveillance, alert prioritization, risk estimation, prescription review, and other pharmacy-related decisions. Yet institutions commonly govern their acquisition, technical installation, clinical validation, and day-to-day use through separate processes that do not establish a coherent decision about whether an algorithm should be allowed to enter, remain within, or leave medication-use practice. This article proposes a Pharmacy Algorithm Ga
No takes yet. Share an insight, caveat, or question.
Schneider et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: